Satyendra Meena, Shrirang Joshi, Sanjeev Bhoi
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Trigeminal neuralgia (TN) is a debilitating facial pain syndrome that is often difficult to manage with standard treatments. Although specific regional anaesthesia techniques are available, they are rarely practised in the Emergency Department (ED). We discuss three cases of patients with severe, intractable TN pain unresponsive to oral medications, where an infraorbital nerve block (IONB) was performed for pain relief. IONB using an intraoral (classical) approach, a 30-gauge needle was inserted at the infraorbital foramen after antiseptic preparation, and 1 mL of 2% lignocaine combined with 1.5 mL of 0.5% bupivacaine was administered. All three patients experienced immediate pain relief, and no immediate adverse effects were observed. Follow-up over six months showed that two out of three patients had long-lasting pain relief, supporting the potential of IONB using local anaesthetics as a viable intervention for sustained pain relief. This case series highlights the effectiveness of IONB as an alternative treatment for trigeminal neuralgia in patients who do not respond adequately to conventional pharmacologic therapies in the emergency setting.
Meena S, Joshi S, Bhoi S. A Shot at Relief: A Case Series on Infraorbital Nerve Block for Intractable Trigeminal Neuralgia in the ED. Indian J Emerg Med. 2025;11(4):253-8.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| June 16, 2025 | July 21, 2025 | December 30, 2025 |
Monday 27 July 2026, 23:56:45 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | June 16, 2025 |
| Accepted | July 21, 2025 |
| Published | December 30, 2025 |
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.